CZ256991A3 - process for preparing l-threonine by fermentation using the production strain escherichia coli 472 t-23 - Google Patents

process for preparing l-threonine by fermentation using the production strain escherichia coli 472 t-23 Download PDF

Info

Publication number
CZ256991A3
CZ256991A3 CS912569A CS256991A CZ256991A3 CZ 256991 A3 CZ256991 A3 CZ 256991A3 CS 912569 A CS912569 A CS 912569A CS 256991 A CS256991 A CS 256991A CZ 256991 A3 CZ256991 A3 CZ 256991A3
Authority
CZ
Czechia
Prior art keywords
threonine
fermentation
escherichia coli
preparing
production strain
Prior art date
Application number
CS912569A
Other languages
Czech (cs)
Inventor
Jiri Rndr Drsc Plachy
Karel Ing Bezdek
Petr Ing Csc Pilat
Alexandr Hano
Gabriela Ing Borosova
Michal Ing Drsc Bucko
Original Assignee
Vyzk Ustav Antibiotik A Biotra
Biotika
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vyzk Ustav Antibiotik A Biotra, Biotika filed Critical Vyzk Ustav Antibiotik A Biotra
Priority to CS912569A priority Critical patent/CZ279974B6/en
Priority to SK256991A priority patent/SK256991A3/en
Publication of CZ256991A3 publication Critical patent/CZ256991A3/en
Publication of CZ279974B6 publication Critical patent/CZ279974B6/en

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Description

Oblast techniky.....Technology .....

Vynález se týká způsobu fermentačn za využití mutovaného kmene Escherichia coli 472 T-23 ~~The present invention relates to a fermentation method using a mutated strain of Escherichia coli 472 T-23

Dosavadní stav technikyBACKGROUND OF THE INVENTION

Mutant Escherichia coli 472 T-23 s amplifikováným genem - pro homoserindehydrogenasu, s rezistencí vůči penicilinu a_____ s částečnou dependencí na isoleucin, viz. US 4,278.765,hromadil v produkčním médiu zaočkovaném inokulem vyrostlým v médiu s 0,2% kvasničného extraktu jako zdrojem isoleucinu při kultivaci ve fermentační ch tancích až 40 g/1 threoninu při konverzi 33% vztaženo na sacharózu. Přítomnost vhodných zdrojů isoleucinu v médiu kromě vlivu na produkci se projevil také zvýšením genetické stability produkčních kmenů, obsahujících plazmidy a připravených metodami genového inženýrství, viz. Agric.Biol.Chem., 54, 619, 1990.Escherichia coli 472 T-23 mutant with amplified gene - for homoserindehydrogenase, with penicillin resistance a_____ with partial isoleucine dependence, see. US 4,278,765, accumulated in inoculum inoculated media grown in media with 0.2% yeast extract as the source of isoleucine when cultured in fermentation tanks up to 40 g / l threonine at a conversion of 33% based on sucrose. The presence of suitable sources of isoleucine in the medium, in addition to its effect on production, has also resulted in an increase in the genetic stability of plasmid-containing production strains prepared by genetic engineering methods. Chem. Chem., 54, 619 (1990).

Podstata vynálezuSUMMARY OF THE INVENTION

Podštata vynálezu spočívá ve fermentační přípravě L-threoninu s využitím produkčního kmenu Escherichia coli 472 T-23 v médiu, obsahujícím isoleucin v koncentraci 0,3 až 1,0 g/1, tl·* výhodně 0,5 až 0,7 g/1.The present invention is based on the fermentation preparation of L-threonine using a production strain of Escherichia coli 472 T-23 in a medium containing isoleucine at a concentration of 0.3 to 1.0 g / l, preferably 0.5 to 0.7 g / l. 1.

Udržením optimální koncentrace isoleucinu během kultivace producenta threoninu v měřítku provozních tanků, a to aplikací vhodných kombinací zdrojů isoleucinu, jako cern-steepu, melasy, peptonu, přítomných v médiích v množstvích odpovídajících 0,3 až 1 mg/L, lze zvýšit produkci threoinu po 40 h kultivace až na 73 g/L při konverzi 38% vytaženo na sadharózu.By maintaining the optimal isoleucine concentration during the cultivation of the threonine producer on the scale of the operational tanks by applying appropriate combinations of sources of isoleucine, such as cern-steep, molasses, peptone, present in the media in amounts corresponding to 0.3 to 1 mg / L, 40 hours of cultivation up to 73 g / L at a conversion of 38% to sadharose.

Následující příklad provedení způsob vynálezu dokládá, ale ni$ak neomezuje.The following exemplary embodiment illustrates the method of the invention but does not limit it.

Příklad provedení vynálezu.DETAILED DESCRIPTION OF THE INVENTION.

Vlastní fermentace byla provedena v provozním fermentačním tanku o objemu 50 nr^ za stálé teploty 37°G a tlaku, při intenzivním míchání a vzdušnění. K ino kulaci 25 m^ produkční1« ho média, obsahujícího zdroje uhlíku, jako sacharcsu a melasu, j dusíku ze síranu amonného, komplexního zdroje isoleucinu jako corn-steepu, melasy a peptonu v množstvích stanovených na základě obsahu isoleucinu v jeho zdrojích, které umožňují dosažení optimální koncentrace isoleucinu, tAj. 0,3 až 1 mg/1.The fermentation itself was carried out in a 50 µm process fermentation tank at a constant temperature of 37 ° C and pressure, with vigorous stirring and aeration. For the inoculation of a 25 m @ 2 production medium containing carbon sources such as sucrose and molasses, nitrogen from ammonium sulfate, a complex source of isoleucine such as corn steep, molasses and peptone in amounts determined based on the isoleucine content of its sources which allow achieving an optimal isoleucine concentration, i. 0.3 to 1 mg / l.

Toho bylo dosaženo 90% přídavkem corn-steepu a 10% přídavkem .This was achieved by adding 90% corn-steep and 10%.

<-------melasy a sojového peptonu, dále pak dodáním zdroje fosfátu _______________ jako např. dihydrogenfosforečnan draselný, chloridu sodného, stopových prvků, odpěňovadla jako např. sojového oleje a penicilinu G. Bylo přidáno 250 ml suspenze, získané kultivací v laboratorním fermentačním tanku po dobu 24 h za podmínek shodných s podmínkami aplikovanými v produkčním stupni. Proces byl řízen dávkováním roztoku alkalické saaharosy resp. roztoku obsahujícího směs sacharosy a melasy na základě analytického stanovení sacharosy tak, aby koncentrace sacharesy neklesla pod 5 g/1. Během fermentace bylo pH udržováno na hodnotě 7,0 dávkováním 25% roztoku amoniaku. Tímto způso- bem bylo za 40 h kultivace dosaženo produkce 73 g/1 threoninu při konverzi 38% sacharosy. Threonin byl z kultivační tekutiny izolován jednak jako technický produkt, jednak jako krystalický preparát.<------- molasses and soy peptone, then supplying a phosphate source _______________ such as potassium dihydrogen phosphate, sodium chloride, trace elements, antifoams such as soybean oil and penicillin G. 250 ml of suspension obtained by cultivation in a laboratory fermentation tank for 24 h under conditions identical to those applied in the production stage. The process was controlled by the dosing of the alkaline saaharose solution respectively. a solution containing a mixture of sucrose and molasses based on an analytical determination of sucrose so that the concentration of sucrose does not fall below 5 g / l. During fermentation, the pH was maintained at 7.0 by dosing with 25% ammonia solution. In this way, production of 73 g / l of threonine was achieved in 40 h of cultivation with a conversion of 38% sucrose. Threonine was isolated from the culture fluid both as a technical product and as a crystalline preparation.

£ * Průmyslová využitelnost' i, Threonin připravený způsobem podle vynálezu lze využít jak pro výrobu krmných směsí, při vyšší čistotě k výrobě j léčivých prostředků.INDUSTRIAL APPLICABILITY Threonine prepared by the process of the invention can be used both for the production of compound feeds and at higher purity for the manufacture of medicaments.

Claims (2)

PATENTOVÉ NÁROKYPATENT CLAIMS 1. Způsob fermentační přípravy L-threoninu pomocí produkčního kmenu Escharichia coli 472 T-23, vyznačující se tím, že se kultivace provádí v médiu obsahujícím isoleucin v koncentraci 0,3 až 1 mg/1.A method for the fermentative preparation of L-threonine using a production strain of Escharichia coli 472 T-23, characterized in that the cultivation is carried out in a medium containing isoleucine at a concentration of 0.3 to 1 mg / l. 2. Způsob podle bodu 1 vyznačující se tím, že koncentrace isoleucinu v médiu je 0,5 až 0,7 mg/1.2. The method of claim 1 wherein the concentration of isoleucine in the medium is 0.5 to 0.7 mg / L.
CS912569A 1991-08-20 1991-08-20 PROCESS FOR PREPARING L-THREONINE BY FERMENTATION AND USING THE PRODUCTION STRAIN ESCHERICHIA COLI 472 T-23 97: When preparing threonine by fermentation and using therefor the strain Escherichia coli 472 T-23 being partially dependent on isoleucine, having plasmids carrying a threonine operon and a gene for resistance to penicillin, it is possible to produce in a medium with the isoleucine concentration within the limits ensured by a suitable combination of 3 to 1.0 gram per one liter of corn-steep, molass21: 02570-91 11: 279975 CZ279974B6 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CS912569A CZ279974B6 (en) 1991-08-20 1991-08-20 PROCESS FOR PREPARING L-THREONINE BY FERMENTATION AND USING THE PRODUCTION STRAIN ESCHERICHIA COLI 472 T-23 97: When preparing threonine by fermentation and using therefor the strain Escherichia coli 472 T-23 being partially dependent on isoleucine, having plasmids carrying a threonine operon and a gene for resistance to penicillin, it is possible to produce in a medium with the isoleucine concentration within the limits ensured by a suitable combination of 3 to 1.0 gram per one liter of corn-steep, molass21: 02570-91 11: 279975
SK256991A SK256991A3 (en) 1991-08-20 1991-08-20 Method of fermentating preparation of l-treomine by production strain escherichia coli 472 t-23

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS912569A CZ279974B6 (en) 1991-08-20 1991-08-20 PROCESS FOR PREPARING L-THREONINE BY FERMENTATION AND USING THE PRODUCTION STRAIN ESCHERICHIA COLI 472 T-23 97: When preparing threonine by fermentation and using therefor the strain Escherichia coli 472 T-23 being partially dependent on isoleucine, having plasmids carrying a threonine operon and a gene for resistance to penicillin, it is possible to produce in a medium with the isoleucine concentration within the limits ensured by a suitable combination of 3 to 1.0 gram per one liter of corn-steep, molass21: 02570-91 11: 279975

Publications (2)

Publication Number Publication Date
CZ256991A3 true CZ256991A3 (en) 1993-03-17
CZ279974B6 CZ279974B6 (en) 1995-09-13

Family

ID=5363180

Family Applications (1)

Application Number Title Priority Date Filing Date
CS912569A CZ279974B6 (en) 1991-08-20 1991-08-20 PROCESS FOR PREPARING L-THREONINE BY FERMENTATION AND USING THE PRODUCTION STRAIN ESCHERICHIA COLI 472 T-23 97: When preparing threonine by fermentation and using therefor the strain Escherichia coli 472 T-23 being partially dependent on isoleucine, having plasmids carrying a threonine operon and a gene for resistance to penicillin, it is possible to produce in a medium with the isoleucine concentration within the limits ensured by a suitable combination of 3 to 1.0 gram per one liter of corn-steep, molass21: 02570-91 11: 279975

Country Status (2)

Country Link
CZ (1) CZ279974B6 (en)
SK (1) SK256991A3 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116694540A (en) * 2023-08-03 2023-09-05 欧铭庄生物科技(天津)有限公司滨海新区分公司 Escherichia coli and application thereof in threonine production

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116694540A (en) * 2023-08-03 2023-09-05 欧铭庄生物科技(天津)有限公司滨海新区分公司 Escherichia coli and application thereof in threonine production
CN116694540B (en) * 2023-08-03 2023-10-03 欧铭庄生物科技(天津)有限公司滨海新区分公司 Escherichia coli and application thereof in threonine production

Also Published As

Publication number Publication date
SK256991A3 (en) 1995-07-11
CZ279974B6 (en) 1995-09-13

Similar Documents

Publication Publication Date Title
US4529697A (en) Process for producing L-glutamic acid by fermentation
US4774179A (en) Process for preparing a 7-aminocephalosporanic acid compound
US4652527A (en) Process for culturing methylophilus methylotrophus
AU2002323752B2 (en) Microorganism overproducing 5&#39;-xanthylic acid
FR2461753A1 (en) PROCESS FOR THE PREPARATION OF A CEPHALOSPORINE BY FERMENTATION AND MICROORGANISM FOR CARRYING OUT SAID METHOD
Tani et al. Production of L-Serine by a methanol-utilizing bacterium, Arthrobacter globiformis SK-200
FI71766C (en) FRAMSTAELLNING AV ETHANOL GENOM HOEGEFFEKTIV BAKTERIEJAESNING.
CZ256991A3 (en) process for preparing l-threonine by fermentation using the production strain escherichia coli 472 t-23
US4368266A (en) Method for producing L-glutamic acid by fermentation
KR960016871B1 (en) L-valine producing microorganisms and process for producing l-valine by fermentation
US3850750A (en) Preparation of d-({31 ) pantoic acid and/or d-({31 ) pantoyl lactone
KR900007000B1 (en) Novel candida utilis and process for production of protein
KR910002861B1 (en) Production of cephalosporin-c
JP3006907B2 (en) Method for producing L-alanine by fermentation method
KR100868330B1 (en) A method for preparing L-threonine
Suzuki et al. Fermentative Production of Chloramphenicol-analogs (Corynecins) from Sucrose
KR100330705B1 (en) Inosine-producing microorganism and method for preparing inosine using the same
US3196084A (en) Process for preparing cephalosporin c
KR820000908B1 (en) Process for preparation of cephalospkorinc by fermentation
KR880002418B1 (en) Method of producing inosine and guanosine
Kirpekar et al. Effects of glutamate, glucose, phosphate, and alkali metal ions on cephamycin C production by Nocardia lactamdurans in defined media
KR970010566B1 (en) Microorganism producing 5&#39;-inosinic acid
KR900003741B1 (en) 5&#39;-inosinic acid producing microorganism
US3366550A (en) Method for the fermentative production of 5-fluorouracil ribotide
KR830001258B1 (en) Method for producing L-glutamine by microorganisms

Legal Events

Date Code Title Description
IF00 In force as of 2000-06-30 in czech republic
MM4A Patent lapsed due to non-payment of fee

Effective date: 20050820